Literature DB >> 7623908

Variation in the use of cardiac procedures after acute myocardial infarction.

E Guadagnoli1, P J Hauptman, J Z Ayanian, C L Pashos, B J McNeil, P D Cleary.   

Abstract

BACKGROUND: There are large geographic differences in the frequency with which coronary angiography and revascularization are performed. We attempted to assess whether differences in case mix or in the treatment of specific groups of patients may explain this variability. We also assessed the consequences of various patterns of treatment.
METHODS: We studied patients covered by Medicare who were 65 to 79 years of age and were admitted to 478 hospitals with acute myocardial infarctions during 1990 in New York (1852 patients), where the rate of use of cardiac procedures is low, and in Texas (1837 patients), where the rate of use of such procedures is high. We compared the patterns of treatment of clinically similar groups of patients in the two states. We also compared mortality rates and measures of the health-related quality of life.
RESULTS: Coronary angiography was performed more often in Texas than in New York (45 percent vs. 30 percent, P < 0.001). The frequency of use in Texas was significantly higher than that in New York for all the clinical subgroups of patients analyzed except those at greatest risk for reinfarction. Over a two-year period, the adjusted likelihood of death was lower in New York than in Texas (hazard ratio, 0.87; 95 percent confidence interval, 0.78 to 0.98). Patients from Texas were 41 percent more likely to report angina (P = 0.002) and 62 percent more likely to say they could not perform activities requiring energy expenditure of 5 or more metabolic equivalents than patients from New York approximately two years after infarction (P < 0.001).
CONCLUSIONS: Physicians in Texas were more likely to perform angiography than physicians in New York for patients whose conditions allowed more discretion in the use of cardiac procedures. On average, there appears to be no advantage with respect to mortality or health-related quality of life to performing the procedures at the higher rate used in Texas.

Entities:  

Mesh:

Year:  1995        PMID: 7623908     DOI: 10.1056/NEJM199508313330908

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  32 in total

1.  Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors.

Authors:  E S Fisher; J E Wennberg; T A Stukel; J S Skinner; S M Sharp; J L Freeman; A M Gittelsohn
Journal:  Health Serv Res       Date:  2000-02       Impact factor: 3.402

2.  Underuse of invasive procedures among Medicaid patients with acute myocardial infarction.

Authors:  E F Philbin; P A McCullough; T G DiSalvo; G W Dec; P L Jenkins; W D Weaver
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

3.  In-hospital mortality of elderly patients with acute myocardial infarction: data from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry.

Authors:  K K Haase; R Schiele; S Wagner; F Fischer; U Burczyk; R Zahn; S Schuster; J Senges
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

4.  The impact of utilization management on readmissions among patients with cardiovascular disease.

Authors:  D S Lessler; T M Wickizer
Journal:  Health Serv Res       Date:  2000-02       Impact factor: 3.402

5.  The VANQWISH Trial: support for the noninvasive strategy for risk stratification after acute myocardial infarction.

Authors:  G A Beller; K A Brown
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

6.  Risk stratifying patients who survive an acute myocardial infarction.

Authors:  M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

7.  American Society of Nuclear Cardiology project on myocardial perfusion imaging: measuring outcomes in response to emerging guidelines.

Authors:  R S Gibbons
Journal:  J Nucl Cardiol       Date:  1996 Sep-Oct       Impact factor: 5.952

Review 8.  Risk assessment after myocardial infarction: have the rules changed with thrombolytic therapy?.

Authors:  M S Verani
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

Review 9.  Defining outcomes in older patients with cardiovascular disease.

Authors:  C L Pashos
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

10.  Acute coronary syndromes in the United States and United Kingdom: a comparison of approaches. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group.

Authors:  P C Adams; J S Skinner; M Cohen; R McBride; V Fuster
Journal:  Clin Cardiol       Date:  1998-05       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.